China Pharma Holdings, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2020
Total Assets: $21.1M
Liabilities Breakdown FY2020
Total Liabilities: $13.1M
Asset Breakdown
Total Assets: $21.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $957.7K | 4.5% |
| Accounts Receivable | $501.9K | 2.4% |
| Inventory | $3.7M | 17.5% |
| Property, Plant & Equipment | $15.6M | 73.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $182.1K | 0.9% |
| Other Assets | $207.0K | 1.0% |
Liabilities Breakdown
Total Liabilities: $13.1M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 9.4% |
| Long-Term Debt | $5.2M | 40.0% |
| Other Liabilities | $6.6M | 50.6% |